News Category
NextPlat Corp. reported a 66% reduction in net loss and a gross margin expansion to 35% for Q3 2026, driven by higher-margin 340B pharmacy services an...
Resilient Performance Group has identified a commercial exposure it calls the Landing Gap, the unpriced risk that arises when a drug asset developed u...
BioVersys and GSK will present Phase 2 data on alpibectir-ethionamide for drug-sensitive pulmonary tuberculosis at The Union World Conference on Lung ...
Quantum BioPharma's private placement of Class A multiple voting shares to CEO- and director-affiliated entities raised insider aggregate voting power...
Researchers at the University of Connecticut have identified a possible explanation for why immunotherapy fails in some patients, a finding that could...
Onco-Innovations has agreed to terminate its performance-based funding arrangement with Sorbie, resulting in the cancellation of 5.38 million shares a...
Quantum BioPharma's private placement of multiple voting shares increases insider voting control to 68.22%, raising governance and dilution concerns a...
tZERO's CFTC approval to operate a Designated Contract Market completes its derivatives infrastructure and triggers the first earn-out milestone in it...
Creative Biolabs is promoting three complementary RNA profiling and visualization approaches to help researchers address blind spots in single-cell an...
Lantern Pharma's published Phase 1a data for LP-184 in recurrent glioblastoma, though limited by modest brain tumor exposure, provide a dosing rationa...
MIT researchers have engineered donor immune cells that nearly wiped out lymphoma in mice within three weeks without being rejected, potentially overc...
NanoViricides is advancing its broad-spectrum antiviral drug NV-387 into Phase II clinical trials for measles, addressing an unmet medical need as mea...
The American Heart Association awarded MedRhythms and Vascudyne top honors at its Health Tech Competition, highlighting technologies that could transf...
A randomized trial found that AI-generated preliminary interpretations of echocardiograms were as accurate as those by sonographers and cardiologists ...
Regentis Biomaterials has secured a four-year exclusive distribution agreement with AMI Medical Technologies for its GelrinC knee cartilage implant in...
A preliminary study found that AI analysis of smartwatch ECG recordings can identify left ventricular systolic dysfunction, but results vary between s...
Regentis Biomaterials has signed a four-year exclusive distribution agreement with AMI Medical Technologies to commercialize its GelrinC knee cartilag...
Sino Biological's 4RISE™ platform addresses the critical bottleneck in AI-driven protein design by providing integrated wet-lab validation, enabling f...
Tonix Pharmaceuticals reported a sharp jump in third-quarter revenue driven by strong TONMYA sales, while advancing its clinical pipeline and extendin...
The Stocktoberfest 2026 programming day opened with a keynote by Howard Lindzon and a fireside chat with Barry Ritholtz, underscoring the growing infl...
Lifordi Immunotherapeutics' Phase 1 data for LFD-200, a subcutaneous glucocorticoid antibody-drug conjugate, demonstrate safety and anti-inflammatory ...
GeoVax Labs will implement a 1-for-24 reverse stock split on November 11, 2026, to raise its share price above the $1.00 minimum bid required for cont...
Certified-PEP has introduced a wholesale program to provide qualified research organizations with dedicated accounts, centralized ordering, and access...
The 34th Hong Kong International Optical Fair attracted some 12,000 buyers from 101 countries and regions, underscoring Hong Kong's role as a global g...
A new trial suggests that combining sacubitril and valsartan reduces recurrent irregular heart rhythms after ablation compared to valsartan alone, pot...
A landmark trial shows left bundle branch pacing reduces death, heart failure hospitalization, and pacing-induced cardiomyopathy compared to standard ...
A large trial in India found that a yoga-based cardiac rehabilitation program improved quality of life and walking distance for heart failure patients...
A small feasibility study suggests that using a balloon to block the aorta during out-of-hospital cardiac arrest may improve blood flow to the heart a...
A large trial found that intensive blood pressure lowering below 120 mm Hg did not significantly reduce major cardiovascular events in adults with Typ...
New research presented at the American Heart Association's Scientific Sessions 2026 suggests that discontinuing statins in adults 70 and older without...
New research shows that intensive blood pressure control in stroke survivors reduces the risk of major cardiovascular events by 21%, highlighting the ...
Adding spironolactone to post-stroke care significantly lowers blood pressure and helps more survivors reach recommended targets, potentially reducing...
The Lp(a) HORIZON trial found that while pelacarsen dramatically lowered Lp(a) levels, it did not reduce major adverse cardiovascular events, undersco...
The ZEUS trial found that ziltivekimab, an interleukin-6 inhibitor, did not reduce major cardiovascular events despite lowering inflammation markers i...
Prof. Nancy Ip's receipt of the 2026 UNESCO-Equatorial Guinea International Prize for Research in the Life Sciences highlights breakthroughs in Alzhei...
A new review identifies EGFR signaling as a central driver of mucus hypersecretion in asthma, COPD, and other lung diseases, and evaluates emerging th...
Kumocast.io offers free, live trading signals and price predictions for 50 markets, updated every 30 minutes, with transparent accuracy records and a ...
The Marygold Companies swung to a $1.8 million profit in its fiscal first quarter, driven by a near-doubling of revenue at its USCF Investments unit, ...
SS Innovations' CEO outlines a growth strategy built on 15,000+ SSi Mantra procedures, 200 telesurgeries, a planned 10-acre Indian manufacturing facil...
SS Innovations International reports over 15,000 robotic surgeries and 200 telesurgeries on its SSi Mantra platform, with 66% revenue growth and plans...
A Harvard cost-driver analysis suggests electing Democratic healthcare professionals won't quickly tame rising U.S. healthcare costs, tempering post-m...
Platinum prices have exceeded $1,800 per ounce for the first time since 2011, prompting Bank of America to revise its outlook and signaling a market s...
Quantum BioPharma filed a supplement to its shareholder meeting materials to clarify rounding rules and a 70% voting power cap for its proposed share ...
The 2026 Activated Egg Symposium in Boston will gather leading scientists to explore how human eggs activate and begin development, with implications ...
MEDICLIN's nine-month results show resilience with rising revenue and EBIT, and the company confirms its full-year forecast, signaling stability in a ...
SS Innovations International's SSi Mantra system has enabled 195 telesurgeries, highlighting the potential for remote robotic surgery to expand access...
Quantum BioPharma (NASDAQ: QNTM) is advancing a diversified strategy that combines clinical drug development, consumer wellness, and royalty-based par...
Earth Science Tech Inc. is using its real estate and asset management subsidiary, Avenvi LLC, to support its expanding pharmacy operations and drive l...
